Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
74.8 CHF | +0.54% | +6.10% | +46.95% |
Mar. 20 | Transcript : Cosmo Pharmaceuticals N.V. - Analyst/Investor Day | |
Mar. 20 | Cosmo Pharmaceuticals N.V. Provides Earnings Guidance for the Year 2024 and Revenue Guidance for 2025 | CI |
- Stock Market
- Equities
- COPN Stock
- News Cosmo Pharmaceuticals N.V.